PA-PMI
24.3.2021 16:32:07 CET | Business Wire | Press release
Project Management Institute (PMI), the world's leading association for project professionals and changemakers, today released its annual Pulse of the Profession® report. Although organizations went through major disruption in the past year, and many projects were put on hold, the report found that organizations were able to rise to the challenge. In fact, of those projects that did forge ahead, 73 percent met original goals and business intent compared to 69 percent last year. 62 percent were completed within budget, and 55 percent on time, compared to 59 percent and 53 percent respectively in last year’s report. As a result, wasted investment due to poor project performance declined to 9.4 percent versus 11.4 percent in last year's survey.
Respondents were asked to characterize their organization’s approach to ways of working, and nearly a third (32 percent) said that any and all possible methods were primarily or exclusively used to solve problems. This is a characteristic of a "gymnastic enterprise.” As outlined in the research, gymnastic enterprises are leading organizations who are able to thrive because they focus on outcomes rather than process, with a clear sense of how to balance structure and governance while embracing change. They empower their people to make change happen by enabling them to master different ways of working, to become well-rounded professionals, and to elevate their power skills. Conversely, 30 percent of respondents shared that their organizations primarily or exclusively consider using methods that have proven effective for them in the past. This is a characteristic of a traditional enterprise. The enduring problem that these traditional enterprises face today is that their structures and ways of working remain very rigid in the midst of change.
“Our 2021 Pulse of the Profession research shows how gymnastic enterprises are thriving in The Project Economy by tailoring their ways of working and empowering their people to lead as changemakers,” said Mike DePrisco, Chief Operating Officer of PMI. “By enabling employees to work smarter, elevating power skills, and building business acumen, gymnastic organizations are delivering financial and societal value regardless of the challenges placed before them.”
The report demonstrates how gymnastic enterprises were able to reap success and nimbly shift when compared to traditional enterprises. For example, gymnastic enterprises were more likely to have high levels of organizational agility (48 percent versus 27 percent) combined with frequent use standardized risk management practices (68 percent versus 64 percent). They were able to adapt faster to the pandemic, being far more likely to have undergone business change in 2020. And, they were much more likely to have seen increased productivity (71 percent versus 53 percent) and better project outcomes in 2020—in turn resulting in less wasted investment (9 percent versus 10.5 percent).
Gymnastic enterprises are also using technology to augment human skills and help their people continuously improve, prioritizing the enterprise-wide adoption of complex problem-solving techniques (47 percent versus 35 percent); AI-driven tools (39 percent versus 30 percent); on-demand, microlearning apps (39 percent versus 30 percent); and career assessment tools (37 percent versus 30 percent). With their focus on augmenting human skills, and on creative collaboration, it’s no surprise that gymnastic enterprises put the highest priority on power skills—especially collaborative leadership (54 percent versus 42 percent of traditional enterprises).
By enabling their people to become changemakers, gymnastic enterprises are better able to sense and respond to shocks, drive change, and face the future, knowing that they have the mindset, skills, and tools that it takes to win. These findings attest to just how important it is for organizations to adopt these approaches.
A total of 3,950 project professionals representing a range of industries and regions, including North America, Europe, Asia Pacific, Sub-Saharan Africa, Latin America, South Asia, Middle East/North Africa, and China were surveyed for the report. The survey was also supplemented by in-depth interviews spanning a wide range of industries and regions.
To read more about how gymnastic enterprises are turning ideas into reality, view the full report here .
About Project Management Institute
Project Management Institute (PMI) is the world's leading professional association for a growing global community of millions of project professionals and changemakers worldwide.
As the world’s leading authority on project management, PMI empowers people to make ideas a reality. Through global advocacy, networking, collaboration, research, and education. PMI prepares organizations and individuals at every stage of their career journey to work smarter so they can drive success in a world of change.
Building on a proud legacy dating to 1969, PMI is a “for-purpose” organization working in nearly every country around the world to advance careers, strengthen organizational success, and enable changemakers with new skills and ways of working to maximize their impact. PMI offerings include globally-recognized standards, certifications, online courses, thought leadership, tools, digital publications, and communities.
Visit us at https://www.pmi.org/ , www.projectmanagement.com , https://www.linkedin.com/company/pminstitute , www.facebook.com/PMInstitute , and on Twitter .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210324005712/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
